Articles

Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome

Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Achillion Pharmaceuticals, New Haven, CT, USA
Achillion Pharmaceuticals, New Haven, CT, USA
Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Achillion Pharmaceuticals, New Haven, CT, USA
Achillion Pharmaceuticals, New Haven, CT, USA
Achillion Pharmaceuticals, New Haven, CT, USA
Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Vol. 102 No. 3 (2017): March, 2017 https://doi.org/10.3324/haematol.2016.153312